NAD+ Cell Formula

4. FORMULATION STRATEGY LOGIC

✔ Structure remains standardized for internal R&D consistency and regulatory traceability
✔ Content is customized based on ingredient science and target market positioning

We develop NAD⁺ Cell Formula using multi-dimensional formulation logic based on:

• Regulatory alignment across target markets

Different regions have different compliance expectations (FDA / EFSA / NMPA), especially regarding:

• NAD⁺ precursors classification (dietary ingredient vs. novel ingredient status)
• Allowed dosage ranges for niacin derivatives and cofactors
• Labeling claims related to “cellular energy” and “anti-aging support|”

• Bioavailability & metabolic pathway optimization

NAD⁺ cannot be efficiently delivered in its direct form. Therefore, formulation design focuses on:

• Precursor conversion efficiency (NR / NMN / NADH pathways)
• Enzymatic utilization support (NAMPT / sirtuin-related pathways)
• Cellular uptake enhancement strategies

• Ingredient stability & compatibility engineering

NAD⁺-related compounds are sensitive to:

• Moisture and temperature degradation
• pH instability in liquid systems
• Oxidative stress during processing

We apply stabilization strategies such as:

• Microencapsulation / protective carriers
• Antioxidant co-factor pairing
• Controlled low-temperature blending systems

• Commercial scalability & manufacturing feasibility

All formulations are designed to ensure:

• Scalable GMP-compliant production
• Stable raw material sourcing chain
• Compatible dosage forms (capsule/powder/sachet/ liquid)
• Cost structure alignment with different brand positioning levels (premium/clinical/mass market)

Available formulation strategies:

• Direct active compound system

Focuses on ready-to-use active forms (e.g., NADH or stabilized NAD⁺ complexes)
→ Suitable for premium, fast-positioning products

• Precursor-based NAD⁺ boosting system

Uses NR / NMN / niacin derivatives to support endogenous NAD⁺ synthesis
→ Most stable and globally accepted regulatory pathway

• Synergistic multi-pathway system

Combines:

• NAD⁺ precursors
• Mitochondrial cofactors (CoQ10, PQQ)
• Antioxidant network (glutathione, alpha lipoic acid)

→ Designed for high-performance “cellular energy + anti-aging” positioning

5. OPTIONAL INGREDIENT MODULES

This section defines optional functional modules that can be integrated based on product positioning, regulatory requirements, and target consumer needs.

Each NAD⁺ formulation is built on a core system and can be extended using scientifically validated functional modules.

✔ Modules are selectively applied depending on:

• Target market regulations (FDA / EFSA / NMPA)
• Product positioning (clinical/premium wellness/mass market)
• Delivery format (capsule/powder/sachet/liquid)
• Stability and interaction compatibility

• NAD⁺ Core System/Active Compounds

Primary functional base responsible for NAD⁺ pathway support:

• NAD⁺ precursors (NR / NMN / niacinamide derivatives)
• Reduced NAD forms (NADH where applicable)
• Enzymatic cofactor support for NAD⁺ biosynthesis

• Antioxidant Protection System

Designed to reduce oxidative degradation and support cellular redox balance:

• Glutathione system support
• Alpha-lipoic acid (ALA)
• Vitamin C / E redox pairing systems
• Polyphenol-based stabilization matrices

• Mitochondrial Energy Support System

Enhances ATP production efficiency and cellular energy metabolism:

• Coenzyme Q10 (ubiquinone/ubiquinol forms)
• PQQ (Pyrroloquinoline quinone)
• L-carnitine derivatives
• Magnesium-dependent ATP activation cofactors

• Bioavailability Enhancement System

Improves absorption efficiency and intracellular delivery:

• Liposomal encapsulation systems
• Phospholipid carrier matrices
• Cyclodextrin inclusion complexes
• Absorption enhancers for NAD⁺ precursors

• Cognitive Function Extension System (Optional)

For brain health/focus/mental energy positioning:

• Choline donors (Alpha-GPC / Citicoline)
• Neurotransmitter support cofactors
• Brain mitochondrial energy boosters (PQQ + CoQ10 synergy)

• Beauty & Skin Longevity Extension System (Optional)

For anti-aging beauty positioning:

• Collagen peptide support systems
• Skin redox balance antioxidants
• Cellular repair cofactors (vitamin B3 derivatives)

• Adaptogen Stress Response System (Optional)

For stress resilience and recovery positioning:

• Rhodiola rosea extracts
• Ashwagandha standardized extracts
• Cortisol regulation of adaptogenic complexes

Implementation Rules (Important)

Not all modules are included in every formulation.

Each NAD⁺ Cell Formula is customized by:

• Removing non-relevant modules
• Selecting compatible synergistic systems
• Ensuring regulatory and stability compliance

6. REGULATORY & COMPLIANCE（Pre-Formulation Compliance Framework）

✔ This section follows a standardized structure to ensure global regulatory traceability and market entry feasibility assessment.

Regulatory strategy is integrated at the earliest stage of formulation development to reduce approval risk and avoid post-development compliance failures.

• United States (FDA Compliance Framework)

Formulation design considers:

• Dietary Supplement Health and Education Act (DSHEA) requirements
• New Dietary Ingredient (NDI) notification risk assessment
• GRAS (Generally Recognized As Safe) ingredient validation
• Supplement Facts labeling compliance and claim substantiation boundaries

✔ Early-stage ingredient screening is performed to minimize NDI filing risks where applicable.

• European Union (EFSA / Novel Food Regulation)

We evaluate:

• Novel Food classification status under EU Regulation (EU) 2015/2283
• EFSA safety dossier requirements for botanicals and bioactive compounds
• Maximum permitted levels for vitamins, minerals, and functional compounds
• Health claim compliance under EU Regulation (EC) No 1924/2006

✔ Only pre-cleared or assessable ingredients are advanced into EU-targeted formulations.

• Canada (Natural Health Products – NHP Framework)

Compliance review includes:

• NPN (Natural Product Number) licensing feasibility
• Health Canada monograph alignment (where applicable)
• Permitted medicinal/non-medicinal ingredient classification
• Dosage form and labeling requirements for NHP registration

• Other International Markets (UK/Australia/Asia/Middle East)

Regulatory review is conducted on a case-by-case basis, including:

• UK MHRA / post-Brexit supplement regulations
• TGA (Australia) listed vs registered medicine classification
• ASEAN supplement harmonization guidelines
• GCC / Middle East import compliance requirements

Pre-Formulation Regulatory Risk Assessment (Critical Step)

Before finalizing any NAD⁺ formulation, we conduct a structured compliance feasibility evaluation:

• Ingredient regulatory status mapping (global database screening)
• Claim limitation analysis (structure/function vs therapeutic risk)
• Market-specific formulation adaptation
• Documentation readiness check for export requirements

✔ This process ensures the formulation is not only scientifically viable, but also commercially approvable.

7. QUALITY CONTROL SYSTEM

（Fully Integrated GMP Quality Assurance System）

✔ This section is standardized across all formulations to ensure batch-to-batch consistency, regulatory compliance, and global traceability.

Our quality control system is embedded throughout the entire production lifecycle—from raw material incoming inspection to final product release.

• Certifications: cGMP, ISO 22000, HACCP, FSSC 22000, Kosher, Halal, and FDA Registered.

• Raw Material Identity Verification

Each incoming raw material is verified for authenticity and purity using validated analytical methods, including:

• HPLC (High-Performance Liquid Chromatography)
• FTIR (Fourier Transform Infrared Spectroscopy)
• Reference standard matching against approved specifications

✔ Ensures only authenticated active ingredients enter production.

• Contaminant Safety Assurance

Comprehensive safety screening is conducted in accordance with USP and ICH guidelines:

• Heavy metal analysis (Pb, As, Cd, Hg)
• Microbiological contamination testing (pathogens & total count)
• Pesticide residue screening for botanical ingredients
• Residual solvent control (where applicable)

✔ Ensures compliance with international safety thresholds.

• Product Stability Validation

Formulations undergo stability evaluation under controlled conditions:

• Accelerated stability testing (temperature/humidity stress)
• Long-term stability monitoring
• Physical, chemical, and microbiological integrity assessments over time

✔ Guarantees product performance throughout shelf life.

• Batch Traceability & Retention System

Each production batch is fully traceable through a digitalized quality management system:

• Unique batch coding system
• Retention of sample storage for regulatory review
• Full production record documentation

✔ Enables complete backward traceability from finished product to raw material source.

• Certificate of Analysis (COA) Documentation

Each batch is released with a complete COA package, including:

• Active ingredient assay results
• Safety and contaminant test reports
• Stability confirmation (where applicable)
• Production batch record summary
• ✔ COA is provided as standard documentation for all shipments.

8. PRODUCTION CAPABILITY（Scalable GMP Manufacturing System）

✔ This section defines our validated production capabilities across pilot-scale development and full-scale commercial manufacturing, ensuring smooth transition from formulation to market-ready production.

Our manufacturing system is designed to support high-precision nutraceutical production with consistent quality, scalable output, and regulatory compliance.

• Multi-Form Dosage Manufacturing Capability

We support multiple delivery formats to meet different product positioning requirements:

• 19+ Years of technical manufacturing expertise.

• 810,000 m² state-of-the-art production facility.

• Capsule production (hard capsules/targeted-release systems)
• Powder blending systems (sachets/bulk powder formulations)
• Liquid filling systems (oral solutions/concentrates)
• ✔ Each dosage form is manufactured under controlled GMP conditions to ensure consistency and stability.

• Pilot-to-Commercial Scale Transition System

We provide full lifecycle manufacturing support:

• Lab-scale formulation validation
• Pilot batch production for stability and process optimization
• Full-scale industrial manufacturing for commercial launch

✔ Ensures seamless scale-up without reformulation risk or performance deviation.

• Process Consistency & Batch Control

Manufacturing processes are strictly controlled to ensure reproducibility across batches:

• Standardized mixing and blending protocols
• Controlled environment production systems
• In-process quality monitoring at critical control points

✔ Batch-to-batch variation is controlled with RSD ≤ 5% for key active ingredients.

• Industrial-Scale GMP Manufacturing Capacity

Our production system is designed for high-volume global supply chains:

• Multiple integrated production lines
• Dedicated production scheduling system for large-scale orders
• Flexible capacity allocation for different market demands

✔ Supports both emerging brand launches and established global distribution programs.

• Quality-Integrated Manufacturing Execution

Production is directly integrated with quality control systems:

• In-process testing during manufacturing stages
• Real-time monitoring of critical parameters
• Final release only after full QC approval

✔ Ensures that manufacturing output always meets regulatory-grade standards.

9. MOQ & SCALING MODEL（Phased Manufacturing & Market Scaling Framework）

✔ This section defines a structured scaling model designed to reduce market entry risk and ensure stable transition from validation batches to full commercial production.

Our MOQ strategy is aligned with product validation stages, regulatory readiness, and real-market performance feedback.

• Pilot Batch (Technical Validation Stage)

• 500–1,000 units
• Used for formulation verification, stability confirmation, and initial market testing
• Support early feedback collection for product optimization

✔ Purpose: de-risk formulation before commercial scale investment

• First Commercial Batch (Market Entry Stage)

• 5,000–10,000 units
• Designed for initial market launch and distribution testing
• Allows brand owners to validate consumer response and sales channels

✔ Purpose: bridge between technical validation and commercial rollout

• Full-Scale Production (Market Expansion Stage)

• 100,000+ units per batch
• High-volume manufacturing for established products with validated market demand
• Optimized for cost efficiency, supply chain stability, and repeat orders

✔ Purpose: support long-term brand growth and global distribution

• Flexible Scaling Strategy (Demand-Driven Expansion)

Scaling is not fixed but dynamically adjusted based on:

• Market validation results
• Sales performance feedback
• Regulatory approval status by region
• Supply chain and raw material availability

✔ Enables smooth transition from niche launch to mass-market production without reformulation or process disruption.

10. PROJECT TIMELINE（Standardized Product Development & Delivery Cycle）

✔ This section defines a structured and predictable development timeline to ensure transparent project execution, reduced uncertainty, and controlled commercialization speed.

All timelines are based on validated internal SOPs and may vary slightly depending on formulation complexity and regulatory requirements.

• Requirement Confirmation & Technical Alignment

• 3–5 days
• Includes project briefing, target market analysis, ingredient feasibility review, and regulatory pre-check
• Output: confirmed formulation direction + development roadmap

• Sample Development & Lab Optimization

• 7–14 days
• Includes prototype formulation, ingredient adjustment, and initial sensory/functional validation
• Output: functional sample for client evaluation

• Stability Pre-Testing Phase

• 2–4 weeks
• Includes accelerated stability screening and compatibility assessment of active systems
• Output: preliminary stability validation report

• Pilot Production & Process Validation

• 1–2 weeks
• Includes small-scale GMP production, process parameter optimization, and batch consistency verification
• Output: pilot batch ready for market testing

• Full-Scale Commercial Production

• 2–4 weeks
• Includes industrial manufacturing, quality release testing, and packaging finalization
• Output: market-ready commercial batches

Total Project Timeline

6–10 weeks (depending on formulation complexity, regulatory pathway, and ingredient availability)

11. SUPPLY CHAIN SECURITY（Controlled Raw Material Assurance System）

✔ This section defines our structured supply chain risk management system to ensure raw material continuity, traceability, and regulatory compliance across global manufacturing operations.

Our sourcing system is designed to minimize supply disruption risks while maintaining consistent quality across all production batches.

• Dual Sourcing Strategy for Key Raw Materials

Critical raw materials are sourced through a validated dual-supplier system to reduce dependency risk and ensure continuity of supply:

• Primary and secondary qualified suppliers for key active ingredients
• Cross-validation of specifications between suppliers
• Risk mitigation for geopolitical, seasonal, or logistics disruptions
• ✔ Ensures stable production even under supply chain volatility.

• Approved Vendor List (AVL) Management System

All raw material suppliers are managed under a strict Approved Vendor List system:

• Supplier qualification and audit process before onboarding
• Continuous performance evaluation based on quality and delivery consistency
• Periodic re-qualification and compliance review
• ✔ Only verified suppliers are allowed in the production supply chain.

• Batch-Level COA Verification System

Each incoming raw material batch is verified against the supplier COA and internal testing standards:

• Identity confirmation and purity validation
• Cross-check between the supplier COA and the in-house analytical results
• Discrepancy rejection protocol for non-compliant batches
• ✔ Ensures only compliant raw materials enter manufacturing.

• Strategic Safety Stock Management

We maintain structured inventory buffers for critical raw materials:

• Safety stock coverage up to 6 months (depending on ingredient criticality)
• Forecast-based procurement planning
• Emergency replenishment protocols for high-demand products
• ✔ Prevents production delays and ensures stable delivery schedules.

• Vertical Integration for Selected Botanical Ingredients

For selected botanical raw materials, we maintain upstream control through integrated cultivation systems, including:

• Marigold extract supply chain control (lutein/carotenoids)
• Haematococcus pluvialis cultivation (astaxanthin source)
• Panax notoginseng GAP-certified cultivation base
• Selected herbal raw material farming systems under controlled agricultural standards
• ✔ Vertical integration for selected botanical ingredients ensures supply stability, traceability, and cost control.

12. IP & CONFIDENTIALITY（Intellectual Property Protection Framework）

✔ This section defines the legal and operational framework for protecting client formulations, ensuring confidentiality, exclusivity, and full ownership rights throughout the collaboration process.

Our OEM/ODM model is strictly designed to safeguard client brand assets and prevent any form of unauthorized replication or competition.

• Non-Disclosure Agreement (NDA) – Pre-Development Requirement

A legally binding NDA is available and can be executed prior to any technical discussion, including:

• Formulation concepts and ingredient strategies
• Market positioning and product roadmap
• Supplier and sourcing information (if applicable)
• ✔ No technical disclosure is initiated without confidentiality protection in place.

• Full Formulation Ownership Transfer

All custom-developed formulations are the exclusive property of the client upon project completion and delivery:

• No retention of proprietary formulas under client brand projects
• No reuse of client-specific formulations in any other project
• Full documentation handover, including specifications and COA references
• ✔ Clients retain complete intellectual property rights.

• Optional Exclusivity Agreement

For selected formulations, exclusivity arrangements can be structured based on:

• Target market (regional exclusivity options)
• Product category exclusivity
• Time-bound exclusivity terms
• Volume-based exclusivity conditions
• ✔ Exclusivity terms are customizable depending on the commercial agreement structure.

• Strict OEM-Only Manufacturing Policy

We operate under a strict OEM/ODM business model with no competing brand development using client-specific formulations:

• No in-house brand commercialization of client formulas
• No replication of private-label formulations across clients
• Segregated project management system for each client
• ✔ Ensures zero conflict of interest in product development.

13. AFTER-SALES SUPPORT（Technical Lifecycle Support & Issue Resolution System）

✔ This section defines our post-production technical support framework designed to ensure fast response, structured issue resolution, and continuous regulatory and product lifecycle assistance.

Our support system extends beyond manufacturing to ensure long-term product performance stability and market compliance.

• 24-Hour Technical Response System

A dedicated technical support team is available to respond within 24 hours for:

• Product performance inquiries
• Manufacturing-related technical questions
• Initial assessment of quality or stability concerns
• ✔ Ensures rapid communication and issue acknowledgment.

• 72-Hour Root Cause Analysis (RCA) Protocol

In the event of a quality or performance deviation:

• Structured root cause investigation is initiated within 72 hours
• Cross-functional review involving QC, production, and formulation teams
• Preliminary corrective action proposal provided
• ✔ Enables fast diagnosis and controlled resolution of technical issues.

• Quality Issue Replacement & Corrective Policy

For confirmed manufacturing-related quality issues:

• Batch replacement or compensation policy based on the investigation outcome
• Structured deviation classification system (critical/major/minor)
• Corrective and preventive action (CAPA) implementation
• ✔ Ensures accountability and production reliability.

• Stability & Performance Investigation Support

For stability-related concerns observed in the market:

• Re-evaluation of formulation stability under reported conditions
• Packaging–formulation interaction review
• Shelf-life and degradation pathway analysis
• ✔ Supports continuous product optimization and lifecycle reliability.

• Regulatory Update Advisory Service

We provide ongoing regulatory monitoring and advisory support for:

• Ingredient regulatory status changes (FDA / EFSA / NHP updates)
• Labeling compliance adjustments
• Claim restriction updates across key markets
• ✔ Ensures long-term compliance of marketed products.